Institute for Protein Design

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

QuantNexus is an applied research collective that pioneers the future of molecular discovery through intelligent automation. Their mission is to empower the next generation of scientists by creating a human and AI partnership that advances biology significantly. The platform, NovoQuantNexus, fuses machine intelligence with human creativity to achieve breakthroughs in record time, outpacing conventional methods and pure-AI approaches. Researchers in pharma, biotech, and academia are leveraging this technology to accelerate discovery and redefine possibilities in life sciences.

Amazon Science is a research and development organization within Amazon that focuses on developing new technologies and products in the fields of artificial intelligence, machine learning, and computer science. The organization is home to a team of world-renowned scientists and engineers who are working on a wide range of projects, including developing new algorithms for machine learning, building new computer vision systems, and creating new natural language processing tools. Amazon Science is also responsible for developing new products and services that use these technologies, such as the Amazon Echo and the Amazon Fire TV.

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Google Research is a team of scientists and engineers working on a wide range of topics in computer science, including artificial intelligence, machine learning, and quantum computing. Our mission is to advance the state of the art in these fields and to develop new technologies that can benefit society. We publish hundreds of research papers each year and collaborate with researchers from around the world. Our work has led to the development of many new products and services, including Google Search, Google Translate, and Google Maps.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

GenInnov is a generative innovation fund that provides a platform for investors seeking to be at the forefront of technological advancement. The fund invests in companies driving transformative change across multiple sectors and geographies, prioritizing material innovations with demonstrable profitability and global reach. GenInnov operates with a research-driven approach, focusing on investing in material innovations that are monetizable, profitable, and transformative, rather than incremental. The fund looks at various domains such as technology, robotics, consumer electronics, biotech, healthcare, mobility, and clean tech, aiming to amplify human creativity through machine intelligence.

Valo is a company that uses AI-driven technology to transform the discovery and development of life-changing medicines. They combine machine learning, tissue biology, and patient data to create a suite of powerful capabilities that bring the future of drug discovery and development to bear. Valo's team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers are dedicated to advancing the combined power of technology and patient data.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Google AI is a research and development laboratory focused on advancing the state-of-the-art in artificial intelligence. The company's mission is to develop AI that is beneficial to humanity, and its research focuses on a wide range of topics, including machine learning, computer vision, natural language processing, and robotics. Google AI has developed a number of products and services that use AI, including the Google Assistant, Google Translate, and Gmail's spam filter. The company is also working on developing new AI applications for healthcare, transportation, and other industries.

PyTorch is an open-source machine learning library based on the Torch library. It is used for applications such as computer vision, natural language processing, and reinforcement learning. PyTorch is known for its flexibility and ease of use, making it a popular choice for researchers and developers in the field of artificial intelligence.

Altera is an applied research company focused on building digital humans - machines with fundamental human qualities. Led by Dr. Robert Yang, the team comprises computational neuroscientists, CS and Physics experts from prestigious institutions. Their mission is to create digital human beings that can live, care, and grow with us. The company's early research prototypes began in games, offering a glimpse into the potential of these digital humans.

NVIDIA is a world leader in artificial intelligence computing. The company's products and services are used by businesses and governments around the world to develop and deploy AI applications. NVIDIA's AI platform includes hardware, software, and tools that make it easy to build and train AI models. The company also offers a range of cloud-based AI services that make it easy to deploy and manage AI applications. NVIDIA's AI platform is used in a wide variety of industries, including healthcare, manufacturing, retail, and transportation. The company's AI technology is helping to improve the efficiency and accuracy of a wide range of tasks, from medical diagnosis to product design.

Carnegie Mellon University's School of Computer Science (SCS) is a world-renowned institution dedicated to advancing the field of computer science and training the next generation of innovators. With a rich history of groundbreaking research and a commitment to excellence in education, SCS offers a comprehensive range of programs, from undergraduate to doctoral levels, covering various specializations within computer science. The school's faculty are leading experts in their respective fields, actively engaged in cutting-edge research and collaborating with industry partners to solve real-world problems. SCS graduates are highly sought after by top companies and organizations worldwide, recognized for their exceptional skills and ability to drive innovation.

Experiments with Google is a website that showcases a collection of experiments created by coders using Chrome, Android, AI, AR, and more. The experiments are designed to inspire others to create new experiments and explore the possibilities of these technologies. The website also provides helpful tools and resources for creating experiments.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Flora Incognita is an interactive plant species identification application that combines AI-supported plant identification with citizen science. With the ability to identify over 30,000 plant species, users can save their plant observations and access extensive plant fact sheets. The app is free of charge, advertising-free, and can be used offline, making it ideal for educational purposes and nature conservation initiatives.

System Pro is a cutting-edge platform that revolutionizes the way users conduct research, particularly in the fields of health and life sciences. It offers a fast and dependable method to discover, combine, and place scientific research in context. By leveraging advanced technology, System Pro enhances the efficiency and effectiveness of research processes, empowering users to access valuable insights with ease.

Synthace is a software and expertise platform designed for Discovery Biology Teams to streamline and optimize their experiments in assay development, media optimization, and purification process development. The platform offers software solutions, training, and on-site support from specialists to help scientists conduct experiments more efficiently and effectively. By leveraging multifactorial methods and automation, Synthace aims to accelerate drug discovery processes and deliver faster, definitive results.

Valo is a company that uses AI-driven technology to transform the discovery and development of life-changing medicines. They combine machine learning, tissue biology, and patient data to create a suite of powerful capabilities that bring the future of drug discovery and development to bear. Valo's team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers are dedicated to advancing the combined power of technology and patient data.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

Deepcell is a company that develops technology for single-cell analysis. Their REM-I platform combines label-free imaging, deep learning, and gentle sorting to leverage single cell morphology as a high-dimensional quantitative readout. This allows researchers to gain insights into cells' phenotype and function to address important research questions across biology.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

Allchemy is a resource-aware AI platform for drug discovery. It combines state-of-the-art computational synthesis with AI algorithms to predict molecular properties. Within minutes, Allchemy creates thousands of synthesizable lead candidates meeting user-defined profiles of drug-likeness, affinity towards specific proteins, toxicity, and a range of other physical-chemical measures. Allchemy encompasses the entire resource-to-drug design process and has been used in academic, corporate and classified environments worldwide to: Design synthesizable leads targeting specific proteins Evolve scaffolds similar to desired drugs Design “circular” drug syntheses from renewable materials Interface with and instruct automated synthesis platforms and optimize pilot-scale processes Operate “iterative synthesis” schemes Predict side reactions and create forensic “synthetic signatures” of hazardous/toxic molecules Design synthetic degradation and recovery cycles for various types of feedstocks and functional target molecules

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Wildlife Insights is an AI application that brings cutting-edge technology to wildlife conservation. It streamlines decision-making by providing machine learning models and tools to manage, analyze, and share camera trap data. Users can easily upload, identify, analyze, and discover wildlife through the platform, enabling better decisions to help wildlife thrive globally.

BioloGPT is an AI tool designed to answer biology-related questions with insights and graphs. It provides information on various topics such as maintaining a healthy gut microbiome, foods for a healthy immune system, effects of cannabis on the brain, risks of Covid-19 vaccines, and advancements in psoriasis treatment. The tool is updated daily and cites full papers to support its answers.

Bichos ID de Fucesa is an AI tool that allows users to explore and identify insects, arachnids, and other arthropods using artificial intelligence. Users can discover the most searched bugs, explore new discoveries made by the community, and view curated organisms. The platform aims to expand knowledge about the fascinating world of arthropods through AI-powered identification.

HoloEye.AI is a transformative AI biological intelligence company that leverages cutting-edge artificial intelligence technology to revolutionize the field of biological research. The platform offers advanced AI solutions for analyzing complex biological data, enabling researchers to gain deeper insights and accelerate scientific discoveries.

CellProfiler is an AI tool designed for biologists to analyze and process images automatically. It allows users to load image-processing modules, adjust settings, measure phenotypes, export data, and classify phenotypes using machine learning. The application is user-friendly and provides a seamless experience for biologists to analyze complex or subtle phenotypes in their images.

Salt AI is a development engine tailored for life sciences organizations, aiming to accelerate advancements in the field by enabling faster adoption and utilization of AI technologies. The platform offers reliable and reproducible AI processes, optimized for speed and efficiency, and promotes transparency and collaboration within workflows. With a focus on supporting best-in-class life sciences research models, Salt AI empowers users to enhance their understanding of biological processes through flexible and performant AI solutions.

Lavo Life Sciences is an AI-accelerated crystal structure prediction application that helps in drug development by providing accurate predictions for small molecule drugs. The application utilizes AI technology to optimize solid-state formulations, reduce turnaround time, mitigate risks, and discover novel polymorphs, ultimately streamlining the pharmaceutical research and development process.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

C&EN, a publication of the American Chemical Society, provides the latest news and insights on the chemical industry, including research, technology, business, and policy. It covers a wide range of topics, including analytical chemistry, biological chemistry, business, careers, education, energy, environment, food, materials, people, pharmaceuticals, physical chemistry, policy, research integrity, safety, and synthesis.

Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

Rationale is a cutting-edge decision-making tool powered by advanced AI technology, including the latest GPT model and in-context learning capabilities. It leverages artificial intelligence to provide users with valuable insights and recommendations for making informed decisions across various domains.

Mnemonic AI is an advanced Customer Intelligence tool that offers AI Personas and Digital Twin of the Customer. It helps organizations improve their understanding of individuals by creating data-driven buyer personas and virtual customers. The tool analyzes OCEAN Big Five Personality Traits and Schwartz Universal Values to tailor messages and marketing strategies. Mnemonic AI automates the process of creating personas and updating customer data, providing deep insights for informed decision-making.

functime is a time-series machine learning tool designed to perform forecasting at scale. It provides functions for scoring, ranking, and plotting thousands of forecasts simultaneously. With a focus on guiding users through their first end-to-end forecasting pipeline, functime serves as an AI copilot to analyze trends, seasonality, and causal factors in forecasts. The tool offers a comprehensive API reference and documentation, making it a valuable resource for both beginners and experienced analysts.

Kolank is an AI platform offering a unified API with agent interoperability, automatic model selection, and cost optimization. It enables AI agents to communicate and collaborate efficiently, providing access to a wide range of AI models for text, image, and video processing. With features like load balancing, fallbacks, and performance metrics, Kolank simplifies AI model integration and usage, making it a comprehensive solution for various AI tasks.